U.S. market Closed. Opens in 11 hours 49 minutes

ABUS | Arbutus Biopharma Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
Revenue18.14M39.02M10.99M6.91M6.01M5.90M10.70M1.49M24.87M14.95M15.46M14.18M16.30M21.35M13.78M9.64M15.92M13.60M13.29M12.17M2.73M5.07M3.46M1.77M1.14M1.23M
Cost of Revenue1.40M1.43M1.75M47.48M57.60M57.90M62.68M61.25M51.51M38.71M21.46M18.13M19.49M22.13M16.97M13.25MN/A6.19MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit16.74M37.59M9.23M-40.57M-51.59M-52.00M-51.98M-59.76M-26.63M-23.76M-5.99M-3.94M-3.19M-779.12K-3.19M-3.61M15.92M7.42MN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses94.77M102.24M82.64M64.18M77.36M76.10M80.83M40.53M27.03M9.21M6.16M-37.61M7.14M11.73M5.88M4.73M13.28M9.10M14.38M35.55M37.38M32.79M19.87M10.97M9.31M9.98M
Selling, General & Admin21.07M17.83M17.14M14.72M17.73M16.00M16.13M39.44M26.44M8.68M5.55M26.89M6.18M4.78M3.97M3.62M4.44M3.85M3.78M7.76M6.78M5.52M3.10M2.25M1.57M1.33M
Research & Development73.70M84.41M65.50M47.48M57.60M57.90M62.68MN/AN/AN/AN/AN/AN/AN/AN/AN/A8.43M4.53M8.76M22.32M23.71M21.61M12.85M8.72M7.75M8.65M
Other Operating Expenses69.00K2.23M1.87M1.98M2.03M7.30M2.03M1.09M589.00K529.00K612.84K-64.51M955.45K6.95M1.91M1.11M411.65K720.51K1.83M5.48M6.89M5.66M3.92MN/A0N/A
Operating Income-78.03M-65.46M-73.52M-57.81M-144.07M-89.80M-110.93M-100.29M-53.66M-32.97M-12.15M33.67M-10.32M-12.51M-9.07M-8.34M2.64M-1.68M-1.09M-23.38M-34.65M-27.72M-16.41M-9.20M-8.17M-8.75M
Other Expenses / Income5.18M444.00K-2.73M-5.94M-22.30M6.00M2.20M-388.87M-23.65M-5.87M-1.91M-3.72M468.41K-7.12K-416.09K-3.38M-5.22M19.76M-6.58M-2.17MN/AN/A455.26KN/AN/AN/A
Before Tax Income-72.85M-65.01M-76.25M-63.74M-166.38M-61.40M-108.73M-489.17M-77.31M-38.84M-14.06M29.95MN/AN/AN/A-11.72M-2.58M18.08M-7.67MN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-1.004.44M1.10M1.47M-12.66M-4.30M-24.32M-105.00M-16.18MN/AN/AN/AN/AN/AN/AN/AN/A-2.31K388.32KN/AN/AN/AN/AN/AN/AN/A
Net Income-72.85M-69.46M-77.35M-65.21M-153.72M-57.10M-84.41M-384.16M-61.12M-38.84M-14.06M29.95M-9.73M-12.41M-9.33M-11.72M-2.58M18.08M-8.06M-28.05M-34.08M-26.79M-14.02M-9.20M-8.17M-8.75M
Interest Expenses459.00K1.73M2.86M4.01M2.11M200.00K261.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding165.96M150.94M106.24M75.84M57.09M55.30M54.10M53.05M45.46M22.44M15.30M13.73M11.32M10.33M10.33M8.12M4.77M7.71M7.71M7.70M6.70M6.20M5.07M4.94M2.82M2.16M
Diluted Shares Outstanding165.96M150.94M106.24M75.84M57.09M55.30M54.10M53.05M45.46M22.44M15.30M14.32M11.32M10.33M10.33M8.12M4.77M7.72M7.71M7.70M6.70M6.20M5.07M4.94M2.82M2.16M
EBITDA-76.63M-61.03M-71.52M-57.09M-89.56M-63.30M-106.44M-488.07M-76.72M-38.31M-13.45M30.82M-8.78M-11.38M-7.41M-10.60M-2.17M18.68M-5.27M-26.85M-27.27M-21.21M-10.16M-7.95M-6.87M-7.76M
EBITDA Margin-422.41%-156.41%-650.92%-825.79%-1,489.85%-1,072.88%-994.81%-32,734.67%-308.43%-256.19%-86.98%217.32%-53.83%-53.28%-53.79%-110.00%-13.63%137.29%-39.68%-220.63%-998.31%-418.15%-293.81%-449.45%-602.29%-632.58%
EBIT-72.39M-63.29M-73.39M-59.73M-164.27M-61.20M-108.47M-489.17M-77.31M-38.84M-14.06M29.95M-9.73M-12.41M-9.33M-11.72M-2.58M18.08M-7.67M-28.05M-34.08M-26.79M-14.02M-9.20M-8.17M-8.75M
EBIT Margin-399.04%-162.19%-667.91%-863.96%-2,732.84%-1,037.29%-1,013.76%-32,807.91%-310.80%-259.73%-90.95%211.19%-59.69%-58.14%-67.68%-121.56%-16.22%132.89%-57.72%-230.49%-1,247.26%-528.27%-405.13%-520.56%-716.68%-713.22%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙